DAVID A. RAMSAY - 12 Jan 2022 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO

Role
Director
Signature
/s/ Michael Hearne, by power of attorney for David A. Ramsay
Issuer symbol
N/A
Transactions as of
12 Jan 2022
Net transactions value
$0
Form type
4
Filing time
14 Jan 2022, 20:00:25 UTC
Previous filing
30 Dec 2021
Next filing
22 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LJPC Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 12 Jan 2022 Common Stock 30,000 $4.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest and become exercisable on January 12, 2023 subject to the Reporting Person's continued service to the Issuer through such date.